Anthony Letai - Researcher Profile | RDL Research Database

Publications

4 shown

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

Courtney D. DiNardo , Keith W. Pratz , Vinod Pullarkat +13 more

Abstract Older patients with acute myeloid leukemia (AML) respond poorly to standard induction therapy. B-cell lymphoma 2 (BCL-2) overexpression is implicated in survival of AML...

2018 Blood 1764 citations

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim , Craig H. Mermel , Dale Porter +59 more

2010 Nature 3995 citations

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Courtney D. DiNardo , Brian A. Jonas , Vinod Pullarkat +27 more

In previously untreated patients who were ineligible for intensive chemotherapy, overall survival was longer and the incidence of remission was higher among patients who receive...

2020 New England Journal of Medicine 2459 citations

Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

Rumani Singh , Anthony Letai , Kristopher A. Sarosiek

2019 Nature Reviews Molecular Cell Biology 1923 citations

Frequent Co-Authors

Researcher Info

h-index: 4
Publications: 4
Citations: 10,141
Institution: Dana-Farber Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1993-9013

Impact Metrics

h-index 4

h-index: Number of publications with at least h citations each.